What to expect from PEGS Europe 2023: Day 2
Drug Discovery World
NOVEMBER 9, 2023
Klaus Wagenbauer, PhD, Founder & CEO, Plectonic, on: ‘Programmable DNA-origami-based T cell engagers: PTE’. The luncheon presentations include: Juan Quintana, PhD, Technical Sales Manager, ACROBiosystems, on: ‘Manufacturing high quality proteins for complex applications’. Filip Borgions, Ph.D,
Let's personalize your content